binimetinib

binimetinib
Trade Name
Orphan Indication Treatment Stage IIB-IV melanoma
USA Market Approval USA
USA Designation Date 2013-11-19 00:00:00
Sponsor Array BioPharma, Inc.;125 Cambridge Park Drive, Suite 301;Cambridge, Massachusetts, 02140